• Genetic Tests Identify Risk of Fluoropyrimidine-Induced Toxicity: Ann Moyer, M.D., Ph.D.

  • Sep 10 2024
  • Length: 9 mins
  • Podcast

Genetic Tests Identify Risk of Fluoropyrimidine-Induced Toxicity: Ann Moyer, M.D., Ph.D.

Listen for free

View show details

  • Summary

  • Ann Moyer, M.D., Ph.D., explains how Mayo Clinic Laboratories' unique genetic tests identify patients at high risk of severe reactions to fluoropyrimidines — a type of chemotherapy drug. Test results can guide clinical decision-making for safer cancer treatment.


    Speaker 3: (00:32)
    Would you tell us a little bit about yourself and your history with this testing?

    Speaker 3: (01:25)
    Would you tell us a little more about this assay?

    Speaker 3: (04:57)
    Which patients should have this testing and when should it be performed?

    Speaker 3: (05:30)
    What alternative tests exist and how do they compare?

    Speaker 3: (06:28)
    How are the results used in patient care?
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Show more Show less

What listeners say about Genetic Tests Identify Risk of Fluoropyrimidine-Induced Toxicity: Ann Moyer, M.D., Ph.D.

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available